Sector Chart NGM Biopharmaceuticals, Inc.

Equities

NGM

US62921N1054

Market Closed - Nasdaq 21:00:00 04/04/2024 BST 5-day change 1st Jan Change
1.54 USD -1.28% Intraday chart for NGM Biopharmaceuticals, Inc. -.--% +79.28%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
129M - - - - -
115B
106B
21.96B -
21.87B -
19.21B